Biomet Adds on Cytosol Laboratories

Biomet has added on Cytosol Laboratories, a manufacturer of medical solutions for blood protection and processing. Biomet, which manufactures and markets reconstructive surgery equipment, trauma devices and electrical bone growth stimulators, has been backed by The Blackstone Group, Kohlberg Kravis Roberts, TPG Capital and GS Capital Partners since an $11.4 billion public-to-private buyout in 2007.